Tag: Clinical trials
Roche partners 10 govt hospitals to strengthen clinical trial capabilities in...
Initiative aligns with CDSCO priorities to boost participation of government sites in Phase 3 and 4 Trials
“AI is reshaping clinical trial design and execution, especially in India”
Dr Saurabh Arora, Managing Director, Auriga Research shares insights on the growing influence of AI in the clinical trials ecosystem; company’s latest partnerships, current activities and future outlook
Sun Pharma discontinues studies of its drug for psoriasis & atopic...
The Phase 2 atopic dermatitis study of SCD-044 included 250 people and compared three different dosages of SCD-044 with placebo
Post CDSCO approval, Lilly launches Mounjaro, a first of its kind...
The drug delivers superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials
SunAct Cancer Institute ties up with Singapore’s CytoMed for phase 2...
This is a cutting-edge cancer treatment that uses special immune cells called Gamma Delta T-Cells
Alkem signs licensing deal with Sonnet BioTherapeutics to launch its drug...
Sonnet’s drug candidate “SON-080” has shown encouraging data in phase 1b clinical trial
ICMR signs MOAs with industry & academic partners to advance first-in-human...
The partnership marks a pivotal step towards establishing India’s self-sufficiency in clinical development and advancing indigenous pharmaceutical agents
Polatuzumab offers new hope for DLBCL patients on World Lymphoma Day
The first FDA-approved DLBCL treatment in nearly 20 years, Polatuzumab shows results in reducing relapse and disease progression
IQVIA conducts over 45 vaccine studies in India during last 5...
The company’s success in vaccine trials is driven by its extensive site network, comprising over 130 locations across India
Merck and Daiichi Sankyo collaborate on MK-6070 for global T-cell engager...
The new Agreement includes worldwide co-development and co-commercialization of DLL3 T-cell engager, excluding Japan